Balasegaram, Manica <br/><br/>
Liposomal amphotericin B as a treatment for human leishmaniasis.  [electronic resource] 

 -  Expert opinion on emerging drugs  Dec 2012 
 - 493-510 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7623 
<br/><br/><label>Standard No.: </label>10.1517/14728214.2012.748036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amphotericin B--administration & dosage<br/>Antiprotozoal Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Design<br/>Drugs, Generic--therapeutic use<br/>Health Services Accessibility<br/>Humans<br/>Leishmaniasis--drug therapy<br/>Leishmaniasis, Visceral--drug therapy<br/>Therapeutic Equivalency